Malignant disease & immunosuppression

North and East Devon Health Care Community Shared Care Guidelines – Malignant disease & immunosuppression

Click on the links below to access individual guidelines. 
Hydroxycarbamide for the management of myeloproliferative disorders (June 2017) Mycophenolate mofetil for autoimmune conditions (May 2017)

Archived guidelines

A number of shared care guidelines have been archived, and are available for reference only.

CCGs are not the responsible commissioners for these treatments; these services fall within the specialised services commissioned by NHS England.  Guidance should be provided to GPs by specialist services if requests are made to share care.

Rate this page